Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Practical Management of Cancer Cachexia

Practical Management of Cancer Cachexia In cancer patients, delivery of palliative care during anticancer treatment (i.e., concurrent care) leads to enhanced clinical outcome. Nutrition therapy is part of palliative care and, therefore, should be prescribed to prevent or treat cachexia. Effective nutrition therapy is based on a thorough assessment of weight loss history, eating behaviour, changes in appetite, and the presence of nutrition impact symptoms. By identifying a patient’s needs, the delivery of nutritional care (i.e., counselling, supplements, enteral or parenteral nutrition according to the "maximal use of supportive therapy" approach) has greater likelihood to be highly effective. However, a careful monitoring programme, which includes periodical check of body weight, energy and protein intake, quality of life, ensures constant adaptation of nutritional care to the changing needs of cancer patients. Nutrition therapy is becoming a key component of cancer patients management. In this new role, nutrition therapy is key in allowing cancer patients to receive and complete treatments and in improving quality of life. Whether these effects also translate into longer survival remains to be demonstrated but preliminary results are encouraging. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Practical Management of Cancer Cachexia

Download PDF
10 pages

Loading next page...
 
/lp/springer-journals/practical-management-of-cancer-cachexia-YXuWFKn2Ly
Publisher
Springer Journals
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-017-0049-z
Publisher site
See Article on Publisher Site

Abstract

In cancer patients, delivery of palliative care during anticancer treatment (i.e., concurrent care) leads to enhanced clinical outcome. Nutrition therapy is part of palliative care and, therefore, should be prescribed to prevent or treat cachexia. Effective nutrition therapy is based on a thorough assessment of weight loss history, eating behaviour, changes in appetite, and the presence of nutrition impact symptoms. By identifying a patient’s needs, the delivery of nutritional care (i.e., counselling, supplements, enteral or parenteral nutrition according to the "maximal use of supportive therapy" approach) has greater likelihood to be highly effective. However, a careful monitoring programme, which includes periodical check of body weight, energy and protein intake, quality of life, ensures constant adaptation of nutritional care to the changing needs of cancer patients. Nutrition therapy is becoming a key component of cancer patients management. In this new role, nutrition therapy is key in allowing cancer patients to receive and complete treatments and in improving quality of life. Whether these effects also translate into longer survival remains to be demonstrated but preliminary results are encouraging.

Journal

Oncology and Therapy – Springer Journals

Published: Sep 4, 2017

References

  • Cancer statistics, 2017
    Siegel, RL; Miller, KD; Jemal, A
  • Palliative care reduces morbidity and mortality in cancer
    Rocque, GB; Cleary, JF
  • American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care
    Smith, TJ; Temin, S; Alesi, ER
  • Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial
    Bakitas, MA; Tosteson, TD; Li, Z
  • Definition and classification of cancer cachexia: and international consensus
    Fearon, K; Strasser, F; Anker, SD
  • Cancer cachexia: understanding the molecular basis
    Argiles, JM; Busquets, S; Stemmler, B; Lopez-Soriano, FJ
  • Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index
    Martin, L; Birdsell, L; MacDonald, N
  • Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
    Mir, O; Coriat, R; Blanchet, B
  • Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
    Lieffers, JR; Bathe, OF; Fassbender, K
  • Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance
    Lu, Z; Yang, L; Yu, J
  • Patterns of functional decline at the end of life
    Lunney, JR; Lynn, J; Foley, DJ; Lipson, S; Guralnik, JM
  • Integrating palliative care into the trajectory of cancer care
    Hui, D; Bruera, E
  • Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
    Prado, CM; Sawyer, MB; Ghosh, S
  • The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients
    Muscaritoli, M; Molfino, A; Gioia, G
  • Nutritional support in cancer patients: a position paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)
    Caccialanza, R; Pedrazzoli, P; Cereda, E
  • Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
    Quinten, C; Coens, C; Mauer, M
  • Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
    Sjoblom, B; Gronberg, BH; Wentzel-Larsen, T
  • Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults
    Hamaguchi, Y; Kaido, T; Okumura, S
  • Diagnostic criteria for the classification of cancer-associated weight loss
    Martin, L; Senesse, P; Gioulbasanis, I
  • ESPEN guidelines on nutrition in cancer patients
    Arends, J; Bachmann, P; Baracos, V
  • Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy
    Ravasco, P; Monteiro-Grillo, I; Camilo, M
  • A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings
    Elia, M; Normand, C; Laviano, A; Norman, K
  • A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting
    Elia, M; Normand, C; Norman, K; Laviano, A
  • Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy
    Murphy, RA; Mourtzakis, M; Chu, QS
  • Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT
    Meij, BS; Langius, JAE; Spreeuwenberg, MD
  • Saving lives without new drugs
    Cohen, J
  • Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial
    Waele, E; Mattens, S; Honore’, PM
  • Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
    Cox, S; Powell, C; Carter, B
  • ESPEN guideline: clinical nutrition in surgery
    Weimann, A; Braga, M; Carli, F
  • Adherence to the ERAS protocol is associated with 5-year survival after colorectal cancer surgery: a retrospective cohort study
    Gustafsson, UO; Oppelstrup, H; Thorell, A
  • Exploiting the critical perioperative period to improve long-term cancer outcomes
    Horowitz, M; Neeman, E; Sharon, E; Ben-Eliyahou, S
  • Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity
    Flint, TR; Janowitz, T; Connell, CM
  • Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition
    Bozzetti, F; Cotogni, P; Lo Vullo, S